Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Consumerism

Q&A with a Pandemic Response Expert

How COVID-19 testing, contact tracing, and targeted quarantine may revive consumer and employee confidence.

Partner, Health & Life Sciences, Oliver Wyman

What the future may hold for four big company names looking to become big names in healthcare.

Partner, Health & Life Sciences, Oliver Wyman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Here’s how organizations like Zipongo, ProMedica, and Walmart are strategizing around the food as medicine movement.

Partner, Health & Life Sciences, Oliver Wyman
Vice President, Health Transformation, Walmart
President & CEO, ProMedica
Founder and CEO

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe

Walmart sells 25 percent of all food in the US, with half of Americans stepping inside a Walmart each week.

Vice President, Health Transformation, Walmart
Partner, Health and Life Sciences, Oliver Wyman

Hospital systems will be in a precarious position if they all aim for the same North Star. What might their evolution look like in coming years?

Former Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health and Life Sciences, Oliver Wyman

Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

It's not easy to predict the future of Amazon, Berkshire Hathaway, and JPMorgan. But it is easy to see why incumbents should be making disruption a top priority.

Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts

Insights in your inbox

Subscribe